Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
International Agency for Research on Cancer (2005). Cervix Cancer Screening. IARC handbooks of cancer prevention, Vol. 10. Lyon: IARCPress. [cited 2018 Apr 15]. Available from: http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/index.phpInternational Agency for Research on Cancer (2005)10LyonIARCPress[cited 2018 Apr 15]. Available from:http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/index.phpSearch in Google Scholar
Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 2013; 49: 3262-73. 10.1016/j.ejca.2013.04.024VaccarellaSLortet-TieulentJPlummerMFranceschiSBrayF.Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors20134932627310.1016/j.ejca.2013.04.024Open DOISearch in Google Scholar
Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-0008ZadnikVPrimic ZakeljMLokarKJarmKIvanusUZagarT.Cancer burden in Slovenia with the time trends analysis201751475510.1515/raon-2017-0008Open DOISearch in Google Scholar
Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007; 45: 93-106. 10.1016/j.ypmed.2007.06.007SpenceARGogginPFrancoEL.Process of care failures in invasive cervical cancer: systematic review and meta-analysis2007459310610.1016/j.ypmed.2007.06.007Open DOISearch in Google Scholar
Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson J, Salvarsdóttir A. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988. Gynecol Oncol 1991; 43: 64-70.SigurdssonKHrafnkelssonJGeirssonGGudmundssonJSalvarsdóttirA.Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988199143647010.1016/0090-8258(91)90011-SSearch in Google Scholar
Takac I, Ursic-Vrscaj M, Repse-Fokter A, Kodric T, Rakar S, Mozina A, et al. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia. Eur J Obstet Gynecol Reprod Biol 2008; 140: 82-9. 10.1016/j.ejogrb.2008.02.019TakacIUrsic-VrscajMRepse-FokterAKodricTRakarSMozinaAClinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia200814082910.1016/j.ejogrb.2008.02.019Open DOISearch in Google Scholar
Landy R, Pesola F, Castañón A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer 2016; 115: 1140-46. 10.1038/bjc.2016.290LandyRPesolaFCastañónASasieniP.Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study201611511404610.1038/bjc.2016.290Open DOISearch in Google Scholar
[National Cervical Cancer Screening Programme ZORA.] [Slovenian]. DP ZORA: Kazalniki. [online] https://zora.onko-i.si/ [Accessed 2018 Mar 29]. Available at: https://zora.onko-i.si/publikacije/kazalniki/[Slovenian]DP ZORA: Kazalniki. [online]https://zora.onko-i.si/[Accessed 2018 Mar 29]. Available at:https://zora.onko-i.si/publikacije/kazalniki/Search in Google Scholar
Elfstrom KM, Arnheim-Dahlstrom L, von Karsa L, Dillner J. Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer 2015; 51: 950-68. 10.1016/j.ejca.2015.03.008ElfstromKMArnheim-DahlstromLvon KarsaLDillnerJ.Cervical cancer screening in Europe: quality assurance and organisation of programmes2015519506810.1016/j.ejca.2015.03.008Open DOISearch in Google Scholar
Ivanuš U, Primic Žakelj M. [HPV self-sampling among non-responders to cervical cancer screening programmes: systematic review]. [Slovenian]. Onkologija 2012; 2: 78-86. Available also online (in Slovenian language only): https://www.onko-i.si/fileadmin/onko/datoteke/dokumenti/Onkologija_Letnik_XVI_st_2/7_Onkologija_2_2012_samoodvzem.pdfIvanušUPrimic ŽakeljM.[HPV self-sampling among non-responders to cervical cancer screening programmes: systematic review]. [Slovenian]201227886Available also online (in Slovenian language only):https://www.onko-i.si/fileadmin/onko/datoteke/dokumenti/Onkologija_Letnik_XVI_st_2/7_Onkologija_2_2012_samoodvzem.pdfSearch in Google Scholar
Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015; 51: 2375-85. 10.1016/j.ejca.2015.07.006VerdoodtFJentschkeMHillemannsPRaceyCSSnijdersPJArbynM.Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials20155123758510.1016/j.ejca.2015.07.006Open DOISearch in Google Scholar
Von Karsa L, Arbyn A, De Vuyst H, Dillner J, Dillner L, Franceschi S, et al. (2015). Executive summary. In: European guidelines for quality assurance in cervical cancer screening. Second edition, Supplements. Anttila A, Arbyn A, De Vuyst H, Dillner J, Dillner L, Franceschi S, et al, editors. Luxembourg: Office for Official Publications of the European Union. p. XIII–XXIV. [cited 2018 Apr 10]. Available from: https://publications.europa.eu/en/publication-detail/-/publication/a41a4c40-0626-4556-af5b-2619dd1d5ddc/language-enVon KarsaLArbynADe VuystHDillnerJDillnerLFranceschiS(2015)Executive summaryEuropean guidelines for quality assurance in cervical cancer screeningSecond edition, SupplementsAnttilaAArbynADe VuystHDillnerJDillnerLFranceschiS[cited 2018 Apr 10]. Available from:https://publications.europa.eu/en/publication-detail/-/publication/a41a4c40-0626-4556-af5b-2619dd1d5ddc/language-enSearch in Google Scholar
Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-83. 10.1016/S1470-2045(13)70570-9ArbynMVerdoodtFSnijdersPJVerhoefVMSuonioEDillnerLAccuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis2014151728310.1016/S1470-2045(13)70570-9Open DOISearch in Google Scholar
Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al; Self-Sampling Study Working Group. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011; 104: 248-54. 10.1038/sj.bjc.6606040Giorgi RossiPMarsiliLMCamilloniLIossaALattanziASaniCSelf-Sampling Study Working Group. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)20111042485410.1038/sj.bjc.6606040303189421179038Open DOISearch in Google Scholar
Giorgi Rossi P, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, et al. HPV Self-sampling Italian Working Group. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer 2015; 112: 667-75. 10.1038/bjc.2015.11Giorgi RossiPFortunatoCBarbarinoPBoveriSCaroliSDel MistroAHPV Self-sampling Italian Working Group. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter20151126677510.1038/bjc.2015.11433350125633037Open DOISearch in Google Scholar
Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd ML, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2014; 134: 2223-30. https://doi.org/10.1002/ijc.28545BrobergGGyrd-HansenDMiao JonassonJRydMLHoltenmanMMilsomIIncreasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP a Swedish randomized controlled trial2014134222330https://doi.org/10.1002/ijc.2854524127304Search in Google Scholar
Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of testkits increases screening participation more than timely opt-in procedures - a randomized controlled trial. BMC Cancer 2018; 18: 273. 10.1186/s12885-018-4165-4TranbergMBechBHBlaakærJJensenJSSvanholmHAndersenB.Preventing cervical cancer using HPV self-sampling: direct mailing of testkits increases screening participation more than timely opt-in procedures - a randomized controlled trial20181827310.1186/s12885-018-4165-4584519529523108Open DOISearch in Google Scholar
R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2012. ISBN 3-900051-07-0, URL. Available from: http://www.R-project.org/R Core Team2012ISBN 3-900051-07-0, URL. Available from:http://www.R-project.org/Search in Google Scholar
Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, et al. [Guidelines for management of women with cervical precancerous lesions]. [Slovenian] In: Ursic-Vrscaj M, editor. Ljubljana: Institute of Oncology Ljubljana; 2011. [cited 2018 Mar 15]. Available at (in Slovene language only): https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdfUrsic-VrscajMRakarSMožinaAKobalBTakačIDeisingerI[Guidelines for management of women with cervical precancerous lesions]Ursic-VrscajMeditor. LjubljanaInstitute of Oncology Ljubljana2011[cited 2018 Mar 15]. Available at (in Slovene language only):https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdfSearch in Google Scholar
Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10. 10.1002/ijc.22484BaisAGvan KemenadeFJBerkhofJVerheijenRHSnijdersPJVoorhorstFHuman papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs200712015051010.1002/ijc.2248417205514Open DOISearch in Google Scholar
Wikström I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011; 105: 337-9. 10.1038/bjc.2011.236WikströmILindellMSannerKWilanderE.Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study2011105337910.1038/bjc.2011.236317289821730977Open DOISearch in Google Scholar
Sanner K, Wikström I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009; 101: 871-4. 10.1038/sj.bjc.6605194SannerKWikströmIStrandALindellMWilanderE.Self-sampling of the vaginal fluid at home combined with high-risk HPV testing2009101871410.1038/sj.bjc.6605194273684419654577Open DOISearch in Google Scholar
Lam JU, Rebolj M, Møller Ejegod D, Pedersen H, Rygaard C, Lynge E, et al. Human papillomavirus self-sampling for screening nonattenders: opt-in pilot implementation with electronic communication platforms. Int J Cancer 2017; 140: 2212-19. 10.1002/ijc.30647LamJUReboljMMøller EjegodDPedersenHRygaardCLyngeEHuman papillomavirus self-sampling for screening nonattenders: opt-in pilot implementation with electronic communication platforms201714022121910.1002/ijc.30647551613828195317Open DOISearch in Google Scholar
Cadman L, Wilkes S, Mansour D, Austin J, Ashdown-Barr L, Edwards R, et al. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. J Med Screen 2015; 22: 28-37. 10.1177/0969141314558785CadmanLWilkesSMansourDAustinJAshdown-BarrLEdwardsRA randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening201522283710.1177/096914131455878525403717Open DOISearch in Google Scholar
Kitchener H, Gittins M, Cruickshank M, Moseley C, Fletcher S, Albrow R, et al. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial. J Med Screen 2017. 10.1177/0969141317696518 [Epub ahead of print]KitchenerHGittinsMCruickshankMMoseleyCFletcherSAlbrowRA cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial201710.1177/0969141317696518[Epub ahead of print]595656928530513Open DOISearch in Google Scholar
Dugué PA, Lynge E, Rebolj M. Mortality of non-participants in cervical screening: Register-based cohort study. Int J Cancer 2014; 134: 2674-82. 10.1002/ijc.28586DuguéPALyngeEReboljM.Mortality of non-participants in cervical screening: Register-based cohort study201413426748210.1002/ijc.2858624288241Open DOISearch in Google Scholar
Učakar V, Poljak M, Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2012; 30: 116-20. 10.1016/j.vaccine.2011.10.066UčakarVPoljakMKlavsI.Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study2012301162010.1016/j.vaccine.2011.10.06622080175Open DOISearch in Google Scholar
Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygård M. Self-Sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian Cervical Cancer Screening Programme. PLoS One 2016; 11: e0151978. 10.1371/journal.pone.0151978EnerlyEBondeJScheeKPedersenHLönnbergSNygårdM.Self-Sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian Cervical Cancer Screening Programme201611e015197810.1371/journal.pone.0151978483059627073929Open DOISearch in Google Scholar
Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer 2012; 130: 1128-35. 10.1002/ijc.26128GökMvan KemenadeFJHeidemanDABerkhofJRozendaalLSpruytJWExperience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program201213011283510.1002/ijc.2612821484793Open DOISearch in Google Scholar
Gök M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040. 10.1136/bmj.c1040. Erratum in: BMJ 2016; 353: i2823.GökMHeidemanDAvan KemenadeFJBerkhofJRozendaalLSpruytJWHPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study2010340c104010.1136/bmj.c10402016353i2823283714320223872Open DOISearch in Google Scholar
Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 2007; 197: 356.e1-6. 10.1016/j.ajog.2007.07.049CastlePESideriMJeronimoJSolomonDSchiffmanM.Risk assessment to guide the prevention of cervical cancer20071973561610.1016/j.ajog.2007.07.049212871217904958Open DOISearch in Google Scholar